临床内科杂志 ›› 2019, Vol. 36 ›› Issue (10): 689-692.doi: 10.3969/j.issn.1001-9057.2019.10.013

• 论 著 • 上一篇    下一篇

药物联合血浆置换治疗难治性类风湿关节炎的临床观察

  

  • 出版日期:2019-10-15 发布日期:2019-10-30
  • 基金资助:
    2017年度武汉市临床医学科研项目(WX17D26) 

Clinical observation of drugs combined with plasma exchange in the treatment of refractory rheumatoid arthritis

  • Online:2019-10-15 Published:2019-10-30

摘要: 目的 探讨药物联合血浆置换(PE)在难治性类风湿关节炎(RA)治疗中的价值。 方法 将80例难治性RA患者随机分成PE治疗组和对照组各40例,比较两组患者治疗前及治疗后7d、28d、56d的28个关节活动疾病指数(DAS28)、疼痛视觉模拟评分(VAS)、类风湿因子(RF)、红细胞沉降率(ESR)、C反应蛋白(CRP)、抗环瓜氨酸肽(CCP)抗体、淋巴细胞水平及疗效。结果 PE治疗组较对照组治疗后第7d、28d、56d的DAS28、VAS、ESR水平及第7d、28d的RF、抗CCP抗体、CRP水平均明显降低(P<0.05),美国风湿病学会(ACR)20、ACR50、ACR70明显改善(P<0.05)。治疗后第7d、28d PE治疗组CD3+T淋巴细胞比例较治疗前明显升高(P<0.05),CD8+T细胞比例较治疗前明显降低(P<0.05);CD4+T细胞比例较治疗前和同时间对照组均明显升高(P<0.05)。PE治疗组第7d、28d的CD4+/CD8+T淋巴细胞比值较治疗前和与同期对照组均明显升高(P<0.05),而对照组治疗前后比较差异无统计学意义(P>0.05)。PE治疗不良反应轻,对症处理后病情均好转。结论 药物联合PE治疗能迅速缓解难治性RA患者的临床症状,不良反应轻,对难治性RA有明显治疗效果。

关键词: 类风湿关节炎; 血浆置换; T淋巴细胞亚群

Abstract: To evaluate the value of drug combined with plasma exchange (PE) in the treatment of refractory rheumatoid arthritis (RA).〖WT5”HZ〗Methods〓〖WT5”BZ〗A total of 80 cases of refractory RA patients were randomly divided into PE treatment group and control group with 40 cases in each group.Disease activity score 28(DAS28),VAS,rheumatoid factor (RF),erythrocyte sedimentation rate (ESR) ,Creactive protein(CRP),anticyclic citrullinated peptide(CCP) antibodies,lymphocytes and efficacy were compared before treatment and at 7d,28d,and 56d after treatment.〖WT5”HZ〗Results〓〖WT5”BZ〗Compared with the control group,DAS28,VAS,ESR in the PE treatment group were significantly decreased at 7d,28d and 56d after treatment,and RF,antiCCP antibody,CRP were significantly decreased at 7d,28d after treatment (P<0.05).〖JP2〗American college of rheumatology (ACR) 20,ACR50 and ACR70 were significantly〖JP〗 improved (P<0.05).The ratios of CD3+T cells in the PE group was significantly higher at 7d and 28d than those before 〖JP2〗treatment (P<0.05), the ratios of CD8+T lymphocytes were significantly lower than those before treatment(P<0.05), and the ratio of CD4+T cells was significantly higher than those before treatment and at the same period in the control group(P<0.05).The ratio of CD4+/CD8+ T lymphocytes〖JP〗 in the PE treatment group was significantly higher than those before and at 7d,  28d after the treatment(P<0.05),while the difference in the control group before and after treatment was not statistically significant(P>0.05).The adverse reaction of PE treatment was mild,and the condition was improved after symptomatic treatment.〖WT5”HZ〗Conclusion〓〖WT5”BZ〗Drug combined with PE therapy can quickly relieve the clinical symptoms of refractory RA patients with mild adverse reaction,and has an obvious therapeutic effect on refractory RA.

Key words: Arthritis rheumatoid; Plasma exchange; T lymphocyte subsets; Clinical observation